newsfilter
← Latest News
GlobeNewswire·

Aravive Reports First Quarter 2022 Financial Results and Provides Corporate Updates

Reported positive updated data and new biomarker data from Phase 1b Study of Batiraxcept in ccRCC Presented updated modeling data from batiraxcept clinical trials at the AACR annual meeting Dosed first patient in Phase 2 study of batiraxcept in cl